Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 963096, 7 pages
http://dx.doi.org/10.1155/2014/963096
Research Article

Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation

1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2Department of Cardiology, Yinzhou People’s Hospital Affiliated to Medical School of Ningbo University, Ningbo 315040, China
3Clinical Laboratory Center, Yinzhou People’s Hospital Affiliated to Medical School of Ningbo University, Ningbo 315040, China

Received 4 July 2014; Revised 3 November 2014; Accepted 3 November 2014; Published 24 November 2014

Academic Editor: Teresa Zelante

Copyright © 2014 Liu Haibo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Agrawal, “CRP after 2004,” Molecular Immunology, vol. 42, no. 8, pp. 927–930, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Garianda, E. Hirsch, S. Bozza et al., “Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response,” Nature, vol. 420, no. 6912, pp. 182–186, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Breviario, E. M. D'Aniello, J. Golay et al., “Interleukin-1-inducible genes in endothelial cells: cloning of a new gene related to C-reactive protein and serum amyloid P component,” The Journal of Biological Chemistry, vol. 267, no. 31, pp. 22190–22197, 1992. View at Google Scholar · View at Scopus
  5. A. Mantovani, “GCBB. PTX3/TSG14,” in Cytokine Reference, J. Oppenheim and M. Feldmann, Eds., Academic Press, New York, NY, USA, 2002. View at Google Scholar
  6. P. Kunes, Z. Holubcova, M. Kolackova, and J. Krejsek, “Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response,” Mediators of Inflammation, vol. 2012, Article ID 920517, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Introna, V. Vidal Alles, M. Castellano et al., “Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites,” Blood, vol. 87, no. 5, pp. 1862–1872, 1996. View at Google Scholar · View at Scopus
  8. M. S. Rolph, S. Zimmer, B. Bottazzi, C. Garlanda, A. Mantovani, and G. K. Hansson, “Production of the long pentraxin PTX3 in advanced atherosclerotic plaques,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 5, pp. e10–e14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Savchenko, M. Imamura, R. Ohashi et al., “Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions,” Journal of Pathology, vol. 215, no. 1, pp. 48–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Momiyama, A. Kawaguchi, I. Kajiwara et al., “Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study,” Atherosclerosis, vol. 207, no. 1, pp. 272–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. H. Téo, R. T. D. de Oliveira, R. L. Mamoni et al., “Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis,” Cellular Immunology, vol. 281, no. 1, pp. 11–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Brodov, S. Behar, I. Goldenberg, V. Boyko, and P. Chouraqui, “Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] Study),” The American Journal of Cardiology, vol. 104, no. 2, pp. 194–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Inoue, T. Kato, T. Uchida et al., “Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting,” Journal of the American College of Cardiology, vol. 46, no. 2, pp. 239–245, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Inoue, T. Uchida, I. Yaguchi, Y. Sakai, K. Takayanagi, and S. Morooka, “Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis,” Circulation, vol. 107, no. 13, pp. 1757–1763, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Helseth, S. Solheim, T. Opstad, P. Hoffmann, H. Arnesen, and I. Seljeflot, “The time profile of pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention,” Mediators of Inflammation, vol. 2014, Article ID 608414, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. S. Munk, U. M. Breland, P. Aukrust, O. Skadberg, T. Ueland, and A. I. Larsen, “Inflammatory response to percutaneous coronary intervention in stable coronary artery disease,” Journal of Thrombosis and Thrombolysis, vol. 31, no. 1, pp. 92–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Kotooka, T. Inoue, D. Fujimatsu et al., “Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening,” Atherosclerosis, vol. 197, no. 1, pp. 368–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Hudzik, J. Szkodzinski, A. Pietka-Rzycka et al., “Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation,” Journal of Interferon & Cytokine Research, vol. 33, no. 5, pp. 280–284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Palmerini, G. Biondi-Zoccai, D. D. Riva et al., “Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis,” The Lancet, vol. 379, no. 9824, pp. 1393–1402, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Inoue, A. Sugiyama, P. C. Reid et al., “Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 161–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Gottsauner-Wolf, G. Zasmeta, S. Hornykewycz et al., “Plasma levels of C-reactive protein after coronary stent implantation,” European Heart Journal, vol. 21, no. 14, pp. 1152–1158, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. G. V. Greque, C. J. Serrano, C. M. Strunz, A. Soeiro, M. Santos, and F. Pivateli, “Preprocedural statin therapy, inflammation and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation,” Catheterization and Cardiovascular Interventions, 2013. View at Publisher · View at Google Scholar
  23. D. N. Feldman, L. Kim, A. G. Rene, R. M. Minutello, G. Bergman, and S. C. Wong, “Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis,” Catheterization and Cardiovascular Interventions, vol. 77, no. 7, pp. 1020–1030, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. N. Feldman, R. M. Minutello, G. Bergman, I. Moussa, and S. C. Wong, “Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes,” The American Journal of Cardiology, vol. 104, no. 9, pp. 1210–1215, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kastrati, A. Schömig, S. Elezi et al., “Predictive factors of restenosis after coronary stent placement,” Journal of the American College of Cardiology, vol. 30, no. 6, pp. 1428–1436, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Nakamura, J. I. Kotani, K. Kozuma et al., “Effectiveness of paclitaxel-eluting stents in complex clinical patients: insights from the TAXUS Japan postmarket surveillance study,” Circulation Journal, vol. 75, no. 11, pp. 2573–2580, 2011. View at Publisher · View at Google Scholar · View at Scopus